Phibro Animal Health (FRA:PB8) Total Liabilities : €637.7 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Total Liabilities?

Phibro Animal Health's Total Liabilities for the quarter that ended in Sep. 2024 was €637.7 Mil.

Phibro Animal Health's quarterly Total Liabilities increased from Mar. 2024 (€652.23 Mil) to Jun. 2024 (€674.03 Mil) but then declined from Jun. 2024 (€674.03 Mil) to Sep. 2024 (€637.69 Mil).

Phibro Animal Health's annual Total Liabilities increased from Jun. 2022 (€633.12 Mil) to Jun. 2023 (€635.84 Mil) and increased from Jun. 2023 (€635.84 Mil) to Jun. 2024 (€674.03 Mil).

Phibro Animal Health Total Liabilities Historical Data

The historical data trend for Phibro Animal Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Total Liabilities Chart

Phibro Animal Health Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

529.16

500.32

633.12

635.84

674.03

Phibro Animal Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															647.89	643.65	652.23	674.03	637.69

Phibro Animal Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Phibro Animal Health's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	189.653	+	(453.542	+	6.359
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	13.209	+	11.266)
	=	674.0

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	912.449	-	238.419
	=	674.0

Phibro Animal Health's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	159.381	+	(447.335	+	6.44
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	13.547	+	10.991)
	=	637.7

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	870.626	-	232.933
	=	637.7

Phibro Animal Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Phibro Animal Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PAHC:USA

Address

300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712

Website

https://www.pahc.com

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health Headlines

No Headlines